Los Angeles Capital Management LLC Actinium Pharmaceuticals, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 213,950 shares of ATNM stock, worth $250,321. This represents 0.0% of its overall portfolio holdings.
Number of Shares
213,950
Previous 171,180
24.99%
Holding current value
$250,321
Previous $321,000
16.2%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$804,7880.0% of portfolio
-
State Street Corp Boston, MA621KShares$726,6570.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$584,1340.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $29.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...